Suppr超能文献

霉酚酸酯治疗纵隔纤维化。

Treatment of mediastinal fibrosis with mycophenolate mofetil.

机构信息

Clinic and Polyclinic of Pneumology, Bern University Hospital, Bern, Switzerland.

出版信息

Respiration. 2009;78(3):330-3. doi: 10.1159/000209508. Epub 2009 Mar 19.

Abstract

We present the case of a 67-year-old male patient with mediastinal and retroperitoneal fibrosis. In Europe, this is a rare disease. Treatment was established to prevent complications due to strictures or compressions. Because of his diabetes, a therapy of low-dose prednisone combined with mycophenolate mofetil, known as steroid sparing agent, was applied. As a result, the radiological follow-up showed a marked decrease in the mediastinal and retroperitoneal masses.

摘要

我们报告了一例 67 岁男性患者患有纵隔和腹膜后纤维化。在欧洲,这是一种罕见的疾病。治疗的目的是预防由于狭窄或压迫引起的并发症。由于他患有糖尿病,采用了低剂量泼尼松联合霉酚酸酯(一种被称为类固醇节约剂的药物)的治疗方法。结果,放射学随访显示纵隔和腹膜后肿块明显缩小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验